NCT06705257

Brief Summary

Babies born early (under 32 weeks) are at risk of developing lung problems after birth. A major reason for this is that the lungs are not fully developed. Lungs of preterm babies will often collapse in between breathing due to lung immaturity. Applying gentle pressure, using nasal device through their nostril or through the breathing tube helps to prevent this lung collapse. This would help in air-oxygen going to lungs and also makes the babies breathing more comfortable. This gentle pressure is medically called as PEEP/CPAP and could be delivered by breathing machine (ventilator) and CPAP machine, collectively called as "continuous distending pressure (CDP)". Those babies breathing on their own and receiving inadequate CDP would need more breathing support by placing them on breathing machine (ventilator). The longer the baby receives breathing machine support, higher chance of lung injury . Preterm infants who are already on breathing machine, providing sub optimal PEEP/CPAP could also lead to lung damage. Providing optimal PEEP/CPAP could prevent these negative outcomes. Currently there is not enough evidence to suggest optimal PEEP/CPAP in preterm infants. Neonatal units all around the world uses PEEP/CPAP ranging from 4 to 10cm H20 based on their unit practice. Currently available investigations provide limited one time information (e.g. Chest X-ray) regarding whether baby is receiving optimal PEEP/CPAP. Electrical Impedance Tomography (EIT) is a new technology which could provide better information regarding the pressure delivered. Also, this device would provide continuous information as if the clinicians are doing continuous chest X-ray but without any radiation. In this study, the team will assess the effect of different levels of PEEP/CPAP (4 to 10cm H20) on prevention of lung collapse using EIT. This would be studied in premature infants who are on breathing machine support and CPAP machine support.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jun 2025Dec 2026

First Submitted

Initial submission to the registry

November 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 26, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

June 15, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 6, 2026

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

November 19, 2024

Last Update Submit

May 1, 2026

Conditions

Keywords

positive end expiratory pressurePRETERMElectrical Impedance Tomography

Outcome Measures

Primary Outcomes (3)

  • Changes in EIT parameters

    Changes in End expiratory Lung Impedance scores

    total study of 280 minutes

  • Changes in EIT parameters

    Changes in functional lung scores in percentage varying levels of CDP.

    280minutes

  • Changes in EIT

    Changes in silence spaces with varying levels of CDP.

    280 minutes

Secondary Outcomes (4)

  • Secondary outcomes

    Total 280 minutes of study time

  • Secondary outcome measure

    Total study time of 280 minutes

  • Secondary outcome

    Total study time of 280 minutes

  • Secondary outcome

    Total study time of 280minutes

Study Arms (1)

Single arm with increasing and decreasing PEEP levels

EXPERIMENTAL
Diagnostic Test: Studying the effects of varying levels of PEEP using Electrical impedance tomography

Interventions

Feasibility of using EIT, to study the effect of varying levels of PEEP/Continous distending pressure on lung recruitment as measured by changes in functional lung scores and silent spaces in preterm infants (\<32 weeks) who are on mechanical ventilation or receiving primary or post extubation CPAP support.

Single arm with increasing and decreasing PEEP levels

Eligibility Criteria

Age22 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age \<32 weeks based on mother's last menstrual period or first trimester ultrasound dating.
  • Receiving either CPAP or mechanical ventilation respiratory support.
  • Informed written consent from one of the parents.
  • Within the first two weeks of life. Investigators pragmatically chose this period, as there could be considerable lung injury after the first two weeks of life, making it difficult to test our hypothesis. Also, this time period would allow parents to settle down with their stressful preterm delivery and investigators could approach anytime within the first two weeks of life.

You may not qualify if:

  • Major congenital malformations including congenital lung disease and congenital heart disease as ascertained by the medical team.
  • Infants diagnosed with pneumothorax i.
  • Receiving high frequency mechanical ventilation.
  • Infants with concerns of skin integrity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Tees NHS Trust

Middlesbrough, United Kingdom

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Jackie Mitchell

    South Tees NHS foundation trust

    STUDY DIRECTOR

Central Study Contacts

Prakash Kannan Loganathan, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Single arm. All the recruited preterm infants will undergo increasing and decreasing levels of PEEP and the effect of EIT with various PEEP levels will be studied.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2024

First Posted

November 26, 2024

Study Start

June 15, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 6, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After the main study publication
Access Criteria
With valid study protocol and ethical approval.

Locations